Opto Circuits (India) Ltd. (OCI), a manufacturer of invasive and non-invasive medical devices, today announced that Criticare Systems Inc, its wholly owned subsidiary, has signed a long-term development agreement with an OEM customer. The agreement provides for a joint development programme focused on a new modular and MRI-compatible patient monitoring system.
The system will be based on Criticare’s new eVision™platform. The development programme will commence immediately. The resulting new product and iterations thereof are projected to increase revenue, the company said in a statement.
Criticare System’s established partnership with this OEM customer will expand and result in mutual benefits for many years to come. The new product line will be produced by Criticare Systems and will be marketed by the OEM partner under their brand name in all major markets, Vinod Ramnani, managing director, Opto Circuits said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
